JP Morgan Upgrades Adient to Overweight, Lowers Price Target to $25
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsUpgradesPrice Target
JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.
JP Morgan analyst Rajat Gupta upgrades Adient (NYSE:ADNT) from Neutral to Overweight and lowers the price target from $28 to $25.